• Chart
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs
    1. Home
    2. Stocks
    3. Guficbio Share Price

    Gufic Biosciences Share PriceGufic BioSciences

    Small Cap 3.9k Result
    ₹286.9
    0.15 (0.05%)
    As on 01 October, 2023 | 10:09 BSE: 509079 NSE: GUFICBIOISIN: INE742B01025

    Gufic Biosciences Performance

    Day Range

    • Low 285.6
    • High 295.9
    286.9

    52 Week Range

    • Low 177.65
    • High 333
    286.9
    • Open Price287.6
    • Previous Close286.75
    • Volume105354

    Start SIP in Gufic BioSciences

    Start SIP

    Gufic Biosciences Share Price

    • Over 1 Month -5.8%
    • Over 3 Month 22.14%
    • Over 6 Month 52.57%
    • Over 1 Year 32.67%

    Gufic Biosciences Key Statistics

    P/E Ratio 35.1
    PEG Ratio -4.7
    Market Cap Cr 2,781
    Price to Book Ratio 8
    EPS 8.2
    Dividend 0
    Relative Strength Index 49.01
    Money Flow Index 65.8
    MACD Signal 3.16
    Average True Range 12.11

    Gufic Biosciences Investment Rating

    • Master Rating:

    • Gufic Biosciences has an operating revenue of Rs. 720.36 Cr. on a trailing 12-month basis. An annual revenue de-growth of -11% needs improvement, Pre-tax margin of 15% is great, ROE of 22% is exceptional. The company has a debt to equity of 55%, which is bit higher. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 25% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 81 which is a GOOD score indicating consistency in earnings, a RS Rating of 68 which is FAIR indicating the recent price performance, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 87 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    Gufic BioSciences Financials
    IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 195173177175165162
    Operating Expenses Qtr Cr 160141144142132131
    Operating Profit Qtr Cr 353233333332
    Depreciation Qtr Cr 465544
    Interest Qtr Cr 432211
    Tax Qtr Cr 767776
    Net Profit Qtr Cr 211820202120
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 693782
    Operating Expenses Annual Cr 556633
    Operating Profit Annual in Cr 135146
    Depreciation Cr 2217
    Interest Annual Cr 85
    Tax Annual Cr 2731
    Net Profit Annual Cr 8096
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 104
    Cash from Investing Activity Annual Cr -96
    Cash from Financing Annual Activity Cr -3
    Net Cash Flow Annual Cr 5
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 348269
    Fixed Assets Annual Cr 329156
    Total Non Current Assets Annual Cr 397201
    Total Current Assets Annual Cr 464321
    Total Assets Annual Cr 861521
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 3628
    ROE Annual % 2336
    ROCE Annual % 2039
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 2019
    IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr
    Operating Expenses Qtr Cr
    Operating Profit Qtr Cr
    Depreciation Qtr Cr
    Interest Qtr Cr
    Tax Qtr Cr
    Net Profit Qtr Cr
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr
    Operating Expenses Annual Cr
    Operating Profit Annual in Cr
    Depreciation Cr
    Interest Annual Cr
    Tax Annual Cr
    Net Profit Annual Cr
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr
    Cash from Investing Activity Annual Cr
    Cash from Financing Annual Activity Cr
    Net Cash Flow Annual Cr
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr
    Fixed Assets Annual Cr
    Total Non Current Assets Annual Cr
    Total Current Assets Annual Cr
    Total Assets Annual Cr
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs
    ROE Annual %
    ROCE Annual %
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin %

    Gufic Biosciences Technicals

    EMA & SMA

    Current Price
    ₹286.9
    0.15 (0.05%)
    • Bullish Moving Average
    • ___
    • 9
    • Bearish Moving Average
    • ___
    • 7
    • 20 Day
    • ₹289.66
    • 50 Day
    • ₹278
    • 100 Day
    • ₹258.68
    • 200 Day
    • ₹240.59
    • 20 Day
    • ₹296.36
    • 50 Day
    • ₹279.94
    • 100 Day
    • ₹248.3
    • 200 Day
    • ₹229.19

    Gufic Biosciences Resistance and Support

    PIVOT
    ₹289.47
    Resistance
    First Resistance ₹293.34
    Second Resistance ₹299.77
    Third Resistance ₹303.64
    RSI 49.01
    MFI 65.8
    MACD Single Line 3.16
    MACD 0.64
    Support
    First Resistance ₹283.04
    Second Resistance ₹279.17
    Third Resistance ₹272.74

    Gufic Biosciences Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 114,832 3,119,985 27.17
    Week 111,783 4,394,198 39.31
    1 Month 300,449 10,873,254 36.19
    6 Month 270,523 11,616,252 42.94

    Gufic Biosciences Result Highlights

    Gufic BioSciences Synopsis

    NSE-Medical-Generic Drugs

    Gufic Biosciences Lt is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 690.62 Cr. and Equity Capital is Rs. 9.69 Cr. for the Year ended 31/03/2023. Gufic BioSciences Ltd. is a Public Limited Listed company incorporated on 23/07/1984 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24100MH1984PLC033519 and registration number is 033519.
    Market Cap 2,781
    Sales 720
    Shares in Float 2.42
    No of funds 11
    Yield 0.03
    Book Value 8
    U/D Vol ratio 1.6
    LTDebt / Equity 55
    Alpha 0.1
    Beta 0.73

    Gufic BioSciences

    Owner NameJun-23Mar-23Dec-22Sep-22
    Promoters 75%75%75%75%
    Mutual Funds 1.03%1.03%1.03%1.03%
    Foreign Portfolio Investors 0.7%0.72%0.16%0.06%
    Individual Investors 17.83%17.83%18.24%18.28%
    Others 5.44%5.42%5.57%5.63%

    Gufic BioSciences Management

    Name Designation
    Mr. Jayesh P Choksi Chairman & Managing Director
    Mr. Pranav J Choksi WholeTime Director & CEO
    Mr. Pankaj J Gandhi Whole Time Director
    Mr. Dilip B Ghosh Whole Time Director
    Dr. Balram H Singh Non Exe.Non Ind.Director
    Mr. Rabi N Sahoo Independent Director
    Mr. Gopal M Daptari Independent Director
    Mr. Shreyas K Patel Independent Director
    Mr. Shrirang V Vaidya Independent Director
    Dr. Anu S Auora Independent Director

    Gufic Biosciences Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Gufic Biosciences Corporate Action

    Date Purpose Remarks
    2023-08-11 Quarterly Results & ESOP
    2023-05-29 Audited Results & Final Dividend
    2023-02-10 Quarterly Results
    2022-11-11 Quarterly Results
    2022-08-11 Quarterly Results

    Gufic BioSciences MF Shareholding

    Name Amount(cr)
    ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth 3174
    SBI Healthcare Opportunities Fund Regular Payout Inc Dist cum Cap Wdrl 2033
    Quant Business Cycle Fund Regular Growth 426
    Motilal Oswal Nifty Microcap 250 Index Fund Regular Growth 324
    Quant Healthcare Fund Regular Growth 137
    • Company Name
    • CMP
    • Chg(%)
    • Company Name
    • CMP
    • Chg(%)

    Gufic BioSciences FAQs

    What is Share Price of Gufic BioSciences ?

    Gufic BioSciences share price is ₹286 As on 01 October, 2023 | 09:55

    What is the Market Cap of Gufic BioSciences ?

    The Market Cap of Gufic BioSciences is ₹2781.3 Cr As on 01 October, 2023 | 09:55

    What is the P/E ratio of Gufic BioSciences ?

    The P/E ratio of Gufic BioSciences is 35.1 As on 01 October, 2023 | 09:55

    What is the PB ratio of Gufic BioSciences ?

    The PB ratio of Gufic BioSciences is 8 As on 01 October, 2023 | 09:55

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support desk helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
    ©2023, 5Paisa Capital Ltd. All Rights Reserved.
    We are ISO 27001:2013 Certified.